Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The global diabetes model: user friendly version 3.0.

J B Brown1, A Russell, W Chan

  • 1Center for Health Research, 3800 N. Interstate Avenue, Portland, OR 97227-1110, USA. jonathan.brown@kp.org

Diabetes Research and Clinical Practice
|November 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Defence Engagement (Health) to progress the Women Peace and Security agenda.

BMJ military health·2024
Same author

Important Considerations for ADHD 'Patient and Public' Involvement and Engagement in Research.

Medical research archives·2023
Same author

Measurement is the foundation of research and theory on children's eating behaviours: Current issues and directions for progress.

Appetite·2023
Same author

Infants later diagnosed with autism have lower canonical babbling ratios in the first year of life.

Molecular autism·2022
Same author

Exploring the Cognitive Model of Social Anxiety in Autistic Young People-The Central Role of Bodily Symptoms.

Journal of autism and developmental disorders·2021
Same author

Zonisamide safety in pregnancy: Data from the UK and Ireland epilepsy and pregnancy register.

Seizure·2021
Same journal

One-hour glucose-defined metabolic phenotypes in youth with obesity: early β-cell impairment across the spectrum of dysglycemia.

Diabetes research and clinical practice·2026
Same journal

A systematic review on the role of diet in managing pre-existing diabetes during pregnancy.

Diabetes research and clinical practice·2026
Same journal

Effects of garlic supplementation on glycemic indices in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.

Diabetes research and clinical practice·2026
Same journal

Consensus recommendations on lipohypertrophy: insights from an international panel of experts.

Diabetes research and clinical practice·2026
Same journal

Cognitive frailty in diabetic patients: A visual analysis based on CiteSpace.

Diabetes research and clinical practice·2026
Same journal

Prevalence, incidence, and 6-years stability of metabolically unhealthy normal weight́s phenotype in u.s. hispanic/latino adults.

Diabetes research and clinical practice·2026
See all related articles

The Global Diabetes Model (GDM) Release 3.0 is a microsimulation tool that predicts health outcomes and costs for type 2 diabetes patients. It uses risk factors to forecast complications, survival, and healthcare expenses.

Area of Science:

  • Diabetes research
  • Health economics
  • Epidemiological modeling

Background:

  • Type 2 diabetes poses a significant global health burden, necessitating accurate prediction of disease progression and associated costs.
  • Existing models may not fully capture the dynamic interplay of risk factors and long-term complications in diverse diabetic populations.

Purpose of the Study:

  • To describe and document Release 3.0 of the user-friendly version (UFV) of the Global Diabetes Model (GDM).
  • To present a continuous, stochastic microsimulation model for predicting the medical futures of individuals and populations with type 2 diabetes.

Main Methods:

  • The GDM utilizes a continuous, stochastic microsimulation approach.
  • Incidence rate functions for microvascular and macrovascular complications are derived from published studies and Kaiser Permanente Northwest Region data.

Related Experiment Videos

  • Key risk factors incorporated include HbA1c, blood pressure, cholesterol levels, smoking, and aspirin use.

    • Main Results:

    • The GDM predicts various medical events such as diabetic eye disease, nephropathy, neuropathy, amputations, myocardial infarction, stroke, and heart failure.
    • The model also forecasts survival, quality of life (utilities), and medical care costs.
    • Release 3.0 offers an enhanced user-friendly version (UFV) for broader accessibility.

    Conclusions:

    • The GDM Release 3.0 provides a robust tool for forecasting the long-term medical trajectory of type 2 diabetes.
    • This model can aid in healthcare planning, resource allocation, and the evaluation of interventions for diabetes management.
    • The UFV enhances the model's utility for researchers and clinicians alike.